Gene Expression Profiling of Malignant Tumor Predict the Therapeutic Response of DC-CIK Immunotherapy
Clinical trial NCT01906632 · COMPLETED
Trial details
- NCT number
- NCT01906632
- Sponsor
- Capital Medical University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2022-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.